Technology areas: Biotechnology & Pharmaceuticals • Computing & Software
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Accencio LLC operates a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There are 2 pending office actions for this portfolio. These actions are handled by 2 distinct examiners and 2 distinct art units.
WELLS, LAUREN QUINLAN is the busiest examiner, with 1 busiest examiner pending office action. This represents one of the 2 pending office actions total. The distribution across two art units indicates different technical focuses for the pending pharmaceutical applications.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PHAM, TUAN A | 1 | 83.6% | +27.0% |
| WELLS, LAUREN QUINLAN | 1 | 49.4% | +59.7% |
| KALLAL, ROBERT JAMES | 1 | 59.4% | +31.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19142568 | SYSTEM AND METHOD FOR EVALUATING CHEMICAL COMPOUND DATA USING AND APPLYING A VIRTUAL LANDSCAPE | PHAM, TUAN A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17571840 | SYSTEM AND METHOD FOR EVALUATING BIOLOGICAL DATA USING AND APPLYING A VIRTUAL LANDSCAPE | KALLAL, ROBERT JAMES | 60d overdue |
| 18044964 | METHODS OF TREATING SYMPTOMS OF CORONAVIRUS INFECTION | WELLS, LAUREN QUINLAN | 4d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17571840 | SYSTEM AND METHOD FOR EVALUATING BIOLOGICAL DATA USING AND APPLYING A VIRTUAL LANDSCAPE | KALLAL, ROBERT JAMES | 60d overdue |
| 18044964 | METHODS OF TREATING SYMPTOMS OF CORONAVIRUS INFECTION | WELLS, LAUREN QUINLAN | 4d overdue |
| 19142568 | SYSTEM AND METHOD FOR EVALUATING CHEMICAL COMPOUND DATA USING AND APPLYING A VIRTUAL LANDSCAPE | PHAM, TUAN A | — |
| Art Unit | Apps |
|---|---|
| 2161 | 1 |
| 1622 | 1 |
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19142568 | SYSTEM AND METHOD FOR EVALUATING CHEMICAL COMPOUND DATA USING AND APPLYING A VIRTUAL LANDSCAPE | PHAM, TUAN A | 2161 | §103 | Non-Final OA | — | Pending | Jun 23, 2025 |
| 18044964 | METHODS OF TREATING SYMPTOMS OF CORONAVIRUS INFECTION | WELLS, LAUREN QUINLAN | 1622 | §102§103§112 | Final Rejection | 4d overdue | Pending | Mar 10, 2023 |
| 17571840 | SYSTEM AND METHOD FOR EVALUATING BIOLOGICAL DATA USING AND APPLYING A VIRTUAL LANDSCAPE | KALLAL, ROBERT JAMES | 1685 | §101§103 | Final Rejection | 60d overdue | Pending | Jan 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAccencio LLC has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Tuan A Pham has the most, with 1 of Accencio LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
